Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 205874
Company: KERYX BIOPHARMS
Company: KERYX BIOPHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
AURYXIA | FERRIC CITRATE | EQ 210MG IRON | TABLET;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/05/2014 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205874s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205874Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
01/19/2024 | SUPPL-29 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205874s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/205874Orig1s029ltr.pdf | |
03/10/2021 | SUPPL-27 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205874s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205874Orig1s027ltr.pdf | |
11/06/2017 | SUPPL-13 | Efficacy-New Indication |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205874s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205874Orig1s013ltr.pdf | |
12/19/2016 | SUPPL-11 | Manufacturing (CMC) |
Label is not available on this site. |
||
11/09/2016 | SUPPL-10 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/02/2016 | SUPPL-8 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/27/2015 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/04/2015 | SUPPL-6 | Manufacturing (CMC) |
Label is not available on this site. |
||
07/14/2015 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
07/21/2015 | SUPPL-4 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205874s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205874Orig1s004ltr.pdf | |
05/22/2015 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/18/2015 | SUPPL-2 | Manufacturing (CMC) |
Label is not available on this site. |
||
11/15/2014 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205874s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205874Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
01/19/2024 | SUPPL-29 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/205874s029lbl.pdf | |
03/10/2021 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205874s027lbl.pdf | |
11/06/2017 | SUPPL-13 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205874s013lbl.pdf | |
07/21/2015 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205874s004lbl.pdf | |
11/15/2014 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205874s001lbl.pdf | |
09/05/2014 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205874s000lbl.pdf |